Literature DB >> 28414398

Tuberous Sclerosis Complex: A Review.

Stephanie Carapetian Randle.   

Abstract

Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome that can present at any age and can affect multiple organ systems. This disorder is usually identified in infants and children based on characteristic skin lesions, seizures, and cellular overgrowth or hamartomas in the heart, brain, and kidneys. Tuberous sclerosis complex is a genetic disorder caused by a mutation in either the TSC1 or TSC2 gene leading to dysfunction of hamartin or tuberin, respectively. Hamartin and tuberin form a protein complex that helps regulate cellular hyperplasia. Accurate diagnosis is essential in implementing appropriate surveillance and treatment to patients with this disorder. Specific guidelines for diagnosis, surveillance, and management have been proposed by the International Tuberous Sclerosis Complex Consensus Group. Treatment of tuberous sclerosis complex is in part symptomatic; however, for certain clinical manifestations, specific treatments may be indicated. [Pediatr Ann. 2017;46(4):e166-e171.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28414398     DOI: 10.3928/19382359-20170320-01

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  17 in total

1.  Genomics: the power, potential and pitfalls of the new technologies and how they are transforming healthcare.

Authors:  Katherine S Josephs; Alison Berner; Angela George; Richard H Scott; Helen V Firth; Katrina Tatton-Brown
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

2.  The brain of the tree pangolin (Manis tricuspis). IX. The pallial telencephalon.

Authors:  Aminu Imam; Adhil Bhagwandin; Moyosore S Ajao; Paul R Manger
Journal:  J Comp Neurol       Date:  2022-05-27       Impact factor: 3.028

3.  Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC).

Authors:  Ofri Vorobichik Berar; Michal Tzadok; Ofira Zloto; Iris Moroz; Idan Hecht; Anne Ampaire Musika; Omer Shlomovitz; Ido-Didi Fabian; Vicktoria Vishnevskia Dai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-01       Impact factor: 3.535

Review 4.  Thoracoabdominal imaging of tuberous sclerosis.

Authors:  Cara E Morin; Nicholas P Morin; David N Franz; Darcy A Krueger; Andrew T Trout; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2018-08-04

5.  Rhinencephalon changes in tuberous sclerosis complex.

Authors:  Renzo Manara; Davide Brotto; Samuela Bugin; Maria Federica Pelizza; Stefano Sartori; Margherita Nosadini; Sara Azzolini; Giorgio Iaconetta; Cecilia Parazzini; Alessandra Murgia; Angela Peron; Paola Canevini; Francesca Labriola; Aglaia Vignoli; Irene Toldo
Journal:  Neuroradiology       Date:  2018-06-17       Impact factor: 2.804

6.  Management of adult tuberous sclerosis complex-related angiomyolipoma: A single-center experience.

Authors:  Terry Li; Meghna Siddoji; Jen Hoogenes; Camilla Tajzler; Nikhita Singhal; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

7.  Investigation of quantitative susceptibility mapping in diagnosis of tuberous sclerosis complex and assessment of associated brain injuries at 1.5 Tesla.

Authors:  Lei Zhang; Hongqiang Xue; Tao Chen; Hongzhe Tian; Xiaohu Wang; Xiaocheng Wei; Huawen Zhang; Hui Ma; Zhuanqin Ren
Journal:  J Clin Transl Res       Date:  2020-03-11

8.  Removal of a temporal lobe cavernous angioma to control epileptic seizures in a patient with tuberous sclerosis complex.

Authors:  Kazuki Sakakura; Ayataka Fujimoto; Naoki Ichikawa; Shimpei Baba; Hideo Enoki; Tohru Okanishi
Journal:  Heliyon       Date:  2020-06-23

9.  Bronchial angiofibroma in tuberous sclerosis complex: A case report and literature review.

Authors:  Peikun Teng; Jing Liu; Deshun Liu; Wenfei Li; Xuedong Liu
Journal:  Am J Med Genet A       Date:  2021-07-10       Impact factor: 2.578

10.  Using genetic buffering relationships identified in fission yeast to reveal susceptibilities in cells lacking hamartin or tuberin function.

Authors:  Ashyad Rayhan; Adam Faller; Ryan Chevalier; Alannah Mattice; Jim Karagiannis
Journal:  Biol Open       Date:  2018-01-17       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.